ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2020

Response to IL-17A inhibitors secukinumab and ixekizumab cannot be explained by genetic variation in the protein-coding and untranslated regions of the IL-17A gene: results from a multicentre study of four European psoriasis cohorts.

L J van Vugt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.